German Parliament Calls for Oversight of Down Syndrome Blood Tests

The Bundestag has passed a motion urging the creation of a monitoring system for non-invasive prenatal tests (NIPT) for Trisomy 21, which have been publicly funded since 2022. The move reflects growing ethical and legal concerns over the tests' implications, though no immediate policy change is enacted. This signals a potential shift in German health policy toward stricter regulation of prenatal screening.